相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Computer-Aided Optimization of Combined Anti-Retroviral Therapy for HIV: New Drugs, New Drug Targets and Drug Resistance
Maurizio Zazzi et al.
CURRENT HIV RESEARCH (2016)
A single-loop recombinant pseudotyped-virus-based assay to detect HIV-1 phenotypic resistance
Shouli Wu et al.
ARCHIVES OF VIROLOGY (2015)
Estimating trends in life expectancy in HIV-positive individuals
Matthias Egger et al.
LANCET GLOBAL HEALTH (2015)
HIV: new drugs, new guidelines
Anna Maria Geretti et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2014)
Contribution of Gag and protease to variation in susceptibility to protease inhibitors between different strains of subtype B human immunodeficiency virus type 1
Katherine A. Sutherland et al.
JOURNAL OF GENERAL VIROLOGY (2014)
Prototypical Recombinant Multi-Protease-Inhibitor-Resistant Infectious Molecular Clones of Human Immunodeficiency Virus Type 1
Vici Varghese et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Panel of Prototypical Recombinant Infectious Molecular Clones Resistant to Nevirapine, Efavirenz, Etravirine, and Rilpivirine
Maya Balamane et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
A non-infectious cell-based phenotypic assay for the assessment of HIV-1 susceptibility to protease inhibitors
Maria Jose Buzon et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Novel Two-Round Phenotypic Assay for Protease Inhibitor Susceptibility Testing of Recombinant and Primary HIV-1 Isolates
Maria C. Puertas et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2012)
Novel Method for Simultaneous Quantification of Phenotypic Resistance to Maturation, Protease, Reverse Transcriptase, and Integrase HIV Inhibitors Based on 3′Gag(p2/p7/p1/p6)/PR/RT/INT-Recombinant Viruses: a Useful Tool in the Multitarget Era of Antiretroviral Therapy
Jan Weber et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Phenotypic characterization of drug resistance-associated mutations in HIV-1 RT connection and RNase H domains and their correlation with thymidine analogue mutations
Renan B. Lengruber et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Full-length HIV-1 Gag determines protease inhibitor susceptibility within in-vitro assays
Ravindra K. Gupta et al.
AIDS (2010)
Panel of Prototypical Raltegravir-Resistant Infectious Molecular Clones in a Novel Integrase-Deleted Cloning Vector
Elizabeth C. Reuman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Combinations of Mutations in the Connection Domain of Human Immunodeficiency Virus Type 1 Reverse Transcriptase: Assessing the Impact on Nucleoside and Nonnucleoside Reverse Transcriptase Inhibitor Resistance
Soumi Gupta et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
A Novel Molecular Mechanism of Dual Resistance to Nucleoside and Nonnucleoside Reverse Transcriptase Inhibitors
Galina N. Nikolenko et al.
JOURNAL OF VIROLOGY (2010)
Clinical relevance of substitutions in the connection subdomain and RNase H domain of HIV-1 reverse transcriptase from a cohort of antiretroviral treatment-naive patients
Atsuko Hachiya et al.
ANTIVIRAL RESEARCH (2009)
Novel Recombinant Virus Assay for Measuring Susceptibility of Human Immunodeficiency Virus Type 1 Group M Subtypes To Clinically Approved Drugs
Kris Covens et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
Panel of prototypical infectious molecular HIV-1 clones containing multiple nucleoside reverse transcriptase inhibitor resistance mutations
E Johnston et al.
AIDS (2005)
Changes in human immunodeficiency virus type 1 Gag at positions L449 and P453 are linked to 150V protease mutants in vivo and cause reduction of sensitivity to amprenavir and improved viral fitness in vitro
MF Maguire et al.
JOURNAL OF VIROLOGY (2002)
Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy
XP Wei et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Comparative analysis of two commercial phenotypic assays for drug susceptibility testing of human immunodeficiency virus type 1
SH Qari et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2002)
A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1
CJ Petropoulos et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
分享论文
